Michael Wayne Kalb Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Michael Wayne Kalb is Executive Vice President & CFO of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,606 shares of CPRX, which is worth approximately $199,487. The most recent transaction as insider was on Nov 21, 2025, when has been sold 2,485 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).